Sunil Karnawat
Chief Commercial OfficerDr. Sunil Karnawat, Ph.D., M.B.A., is Chief Commercial Officer of Rezolute, Inc. from August 18, 2025. He joined Rezolute, Inc. in August 2025. He has years of experience in global commercialization of biopharmaceuticals and medical devices. He has launched products across multiple disease states, including ultra-rare bone and metabolic diseases, diabetes, obesity and rheumatoid arthritis. He served as a Vice President at Cytokinetics and Ultragenyx. At Ultragenyx, he was responsible for leading key commercial functions in launching four ultra-rare disease products, including Crysvita with indications for X-linked Hypophosphatemia and Tumor-induced Osteomalacia. Before that, he led the Market Access teams at Myriad Genetics and Vivus Pharmaceuticals. At Novo Nordisk, he led Analytics and Commercial Operations teams to support the US launch of Victoza. He was a Field Sales Leader at LifeScan, a Johnson & Johnson franchise, for OneTouch blood glucose monitors. He started his career at Deloitte Consulting. His education includes an MBA from the Wharton School of Business at the University of Pennsylvania, a Ph.D. and an M.S. in Engineering from North Dakota State University and a B.E. in Civil Engineering from the College of Engineering in Pune, India.
Positions
- Company NameRezolute, Inc.Stock CodeRZLTPositionChief Commercial OfficerColleagues
- NCNevan Charles ElamFounder, CEO & Acting Chairman of the Board
- DGDaron G. EvansChief Financial & Business Officer
- BKBrian Kenneth RobertsChief Medical Officer
- MRMichael R. DeperroSenior VP & Head of Operations
- GMGilbert M. LabrucherieIndependent Director
- WHWladimir HogenhuisIndependent Director
- NCNerissa C. KreherIndependent Director
- JMJerrold M. OlefskyMember of the Scientific Advisory Board
